Trial Profile
A clinical trial to evaluate the safety and efficacy of the interferon (IFN)-free regimen containing danoprevir and ravidasvir for the treatment of hepatitis C
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 25 Jun 2016
Price :
$35
*
At a glance
- Drugs Danoprevir (Primary) ; Ravidasvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 25 Jun 2016 New trial record